Evidence map›Paper›PMID 8568838›Full record

ReviewThe Journal of membrane biology1995

Sphingolipid metabolites: members of a new class of lipid second messengers.

S Spiegel, S Milstien

Abstract readReview
PubMed Publisher
In one paragraph

Review in The Journal of membrane biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Translational Aspects of Sphingolipid Metabolism in Renal Disorders.International journal of molecular sciences · 2017
    Review
  2. A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2015
    Article
  3. Visualization of the pH-dependent dynamic distribution of G2A in living cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2014
    Article
  4. Article
  5. Review
  6. Review
  7. Immunosuppressive human anti-lymphocyte autoantibodies specific for the type 1 sphingosine 1-phosphate receptor.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2009
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Sphingosine-dependent apoptosis: a unified concept based on multiple mechanisms operating in concert.Proceedings of the National Academy of Sciences of the United States of America · 2004
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Sphingolipids and cell signalling.Journal of inherited metabolic disease · 1998
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S SpiegelDepartment of Biochemistry and Molecular Biology, Georgetown University Medical Center, Washington, DC 20007, USA.
S Milstien

Funding

SPHINGOSINE AS A MODULATOR OF CELLULAR PROLIFERATIONR01GM043880 · NIGMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI SPIEGEL, SARAH · 1990 to 2023
$3.8M
NIGMS NIH HHS 1RO1GM43880
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

LysophospholipidsSecond Messenger SystemsAnimalsCalciumCyclic AMPGrowth SubstancesHumansInositol 1,4,5-TrisphosphateMiceMitosisModels, BiologicalPhosphatidic AcidsPhosphorylcholineProtein Kinase CRatsSphingolipidosesCalciumCyclic AMPGrowth SubstancesInositol 1,4,5-TrisphosphateLysophospholipidsPhosphatidic AcidsPhosphorylcholineProtein Kinase CSphingolipidsSphingosinesphingosine 1-phosphatesphingosine phosphorylcholineTranscription Factor AP-1

Identifiers

PMID8568838

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.